Aptatek BioSciences, a Princeton, NJ-based provider of in-home health monitoring solutions, raised $4M in Seed funding.
The round was led by IP Group, Inc., Canterbury Scientific Limited, and National PKU Alliance.
A spinout from Columbia University led by CEO Dr. Michael Boyce-Jacino, Aptatek BioSciences is a developer of in-home health monitoring solutions for patients with chronic disease.
The company intends to use the funds to accelerate the development and clinical validation of its first product that enables critical in-home monitoring of phenylketonuria (PKU) and to make key hires to expand the team and investigate further applications in chronic kidney disease and medication management.
FinSMEs
18/03/2022